The purpose of the work was to demonstrate that an early stage diagnosis of the interstitial lung disease would allow establishing the proper treatment course and as a result, increase life expectancy and quality in patients with this disorder. More than 200 acute and chronic conditions with inflammatory and fibroproliperative changes comprise the group of diffuse lung diseases. Definitive diagnosis cannot be made based on chest X-ray only.
View Article and Find Full Text PDF